Llwytho...
Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
BACKGROUND: Resistant hypertension is a salt‐retaining condition possibly attributable to inappropriate aldosterone secretion. METHODS AND RESULTS: This study was a secondary analysis of the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) trial. Patients...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Am Heart Assoc |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7763779/ https://ncbi.nlm.nih.gov/pubmed/33222584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.018827 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|